GGrantIndex
← Leaderboards

Daniel L Altschuler

University Of Pittsburgh At Pittsburgh

$9,834,731
Attributed
$9,834,731
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $748.4K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,834,731 · 9

By mechanism

R01$8,638,075 · 5
U01$385,000 · 1
R21$383,491 · 1
R29$256,357 · 1
R03$171,808 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Cyclic Amp

Research focus

Cyclic AmpCellsSignal TransductionMediatingCyclic Amp-Dependent Protein KinasesPathway InteractionsComplexThyroid GlandBaseCell ProliferationPhosphorylationEventCell TypeMembraneProteinsSecond Messenger SystemsHormonesPositioning AttributeInhibitor/AntagonistBiologicalResponseEndocrineFluorescence Resonance Energy TransferScaffold

Grant awards (36)

Novel mechanisms in the control of cAMP dynamics$389,550
R01 · FY2025 · GM · contact PI
Novel mechanisms in the control of cAMP dynamics$389,550
R01 · FY2024 · GM · contact PI
Novel mechanisms in the control of cAMP dynamics$199,044
R01 · FY2024 · GM · contact PI
Novel mechanisms in the control of cAMP dynamics$389,550
R01 · FY2023 · GM · contact PI
Role of soluble adenylyl cyclase in TSH biology$391,250
R01 · FY2022 · GM · contact PI
Role of soluble adenylyl cyclase in TSH biology$391,250
R01 · FY2021 · GM · contact PI
Role of soluble adenylyl cyclase in TSH biology$391,250
R01 · FY2020 · GM · contact PI
Role of soluble adenylyl cyclase in TSH biology$183,197
R01 · FY2020 · GM · contact PI
Role of soluble adenylyl cyclase in TSH biology$391,250
R01 · FY2019 · GM · contact PI
cAMP effector pathways in TSH signaling$360,826
R01 · FY2016 · GM · contact PI
Targeting Epac synergistic component in cAMP signaling$192,500
U01 · FY2016 · GM · contact PI
cAMP effector pathways in TSH signaling$360,826
R01 · FY2015 · GM · contact PI
Targeting Epac synergistic component in cAMP signaling$192,500
U01 · FY2015 · GM · contact PI
cAMP effector pathways in TSH signaling$142,860
R01 · FY2015 · GM · contact PI
cAMP effector pathways in TSH signaling$360,410
R01 · FY2014 · GM · contact PI
cAMP effector pathways in TSH signaling$371,448
R01 · FY2013 · GM · contact PI
Exploiting the cAMP pathway in Chagas Disease Therapy$51,616
R03 · FY2013 · TW · contact PI
Rap 1b as a mitogenic signal in thyroid$322,956
R01 · FY2012 · DK · contact PI
Exploiting the cAMP pathway in Chagas Disease Therapy$54,332
R03 · FY2012 · TW · contact PI
Rap 1b as a mitogenic signal in thyroid$322,956
R01 · FY2011 · DK · contact PI
Exploiting the cAMP pathway in Chagas Disease Therapy$65,860
R03 · FY2011 · TW · contact PI
Rap 1b as a mitogenic signal in thyroid$359,964
R01 · FY2010 · DK · contact PI
Rap 1b as a mitogenic signal in thyroid$363,600
R01 · FY2009 · DK · contact PI
Transduction of the cAMP signal by Rap1$253,449
R01 · FY2008 · CA · contact PI
Transduction of the cAMP signal by Rap1$253,449
R01 · FY2007 · CA · contact PI
Rap 1b as a Mitogenic Signalin Thyroid$286,159
R01 · FY2006 · DK · contact PI
Transduction of the cAMP signal by Rap1$261,018
R01 · FY2006 · CA · contact PI
A Universal Mouse Line to Assess Tumor Clonality$201,261
R21 · FY2006 · RR · contact PI
Rap 1b as a Mitogenic Signalin Thyroid$293,702
R01 · FY2005 · DK
Transduction of the cAMP signal by Rap1$267,300
R01 · FY2005 · CA
A Universal Mouse Line to Assess Tumor Clonality$182,230
R21 · FY2005 · RR
Transduction of the cAMP signal by Rap1$301,050
R01 · FY2004 · CA
Rap 1b as a Mitogenic Signalin Thyroid$294,409
R01 · FY2004 · DK
Rap 1b as a Mitogenic Signaling Thyroid$345,802
R01 · FY2003 · DK
RAPLB AS AN EFFECTOR OF CAMP MEDIATED MITOGENIC ACTION$114,378
R29 · FY2001 · CA
RAPLB AS AN EFFECTOR OF CAMP MEDIATED MITOGENIC ACTION$141,979
R29 · FY2000 · CA